Form 4 for QDEL QuidelOrtho Corp
Accepted 2022-06-01 00:00:00 ET · period of report 2022-05-27 · accession 0000899243-22-020491 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-01 | 2022-05-27 | QDEL | Hodges Michelle A. | SVP, GC | A - Grant | — | +708 | 708 | New | — |
| DM | 2022-06-01 | 2022-05-27 | QDEL | Hodges Michelle A. | SVP, GC | A - Grant | $0.00 | +42.2K | 1,892 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-27 | A | A | 708 | — | 708 | D | — | — | (F1) Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho. |
| 2 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 714 | $0.00 | 714 | D | — · — to — | 714 Common Stock | (F6) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F8) 714 shares will vest in equal installments on December 1, 2022, December 1, 2023 and December 1, 2024. |
| 3 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 1,420 | $0.00 | 1,420 | D | — · — to — | 1,420 Common Stock | (F6) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F9) 473 shares will vest on each of February 1, 2023 and February 1, 2024; 474 shares will vest on February 1, 2025. |
| 4 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 1,260 | $0.00 | 1,260 | D | — · — to — | 1,260 Common Stock | (F6) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F10) 1,260 shares will vest in equal installments on May 25, 2023, May 25, 2024 and May 25, 2025. |
| 5 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 1,559 | $0.00 | 1,559 | D | — · — to — | 1,559 Common Stock | (F6) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F11) 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. |
| 6 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 11,910 | $0.00 | 11,910 | D | — · — to — | 11,910 Common Stock | (F6) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F12) 11,910 shares will vest in equal installments on November 8, 2022, November 8, 2023 and November 8, 2024. |
| 7 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 6,439 | $0.00 | 6,439 | D | — · — to — | 6,439 Common Stock | (F6) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F13) 1,609 shares will vest on January 31, 2023; the remaining 4,830 shares will vest in equal installments on January 31, 2024, January 31, 2025 and January 31, 2026. |
| 8 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 7,256 | $0.00 | 7,256 | D | — · — to — | 7,256 Common Stock | (F6) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F14) 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. |
| 9 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 1,020 | $0.00 | 1,020 | D | — · — to — | 1,020 Common Stock | (F6) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F15) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| 10 | Derivative | Restricted Stock Units | 2022-05-27 | A | A | 204 | $0.00 | 204 | D | — · — to — | 204 Common Stock | (F6) Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. (F16) 204 shares will vest on January 31, 2023. (F15) Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| 11 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 6,438 | $0.00 | 6,438 | D | $103.36 · — to 2032-01-31 | 6,438 Common Stock | (F5) 1,609 shares will vest on each of January 31, 2023 and January 31, 2024; 1,610 shares will vest on each of January 31, 2025 and January 31, 2026. |
| 12 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 2,105 | $0.00 | 2,105 | D | $188.95 · — to 2030-12-01 | 2,105 Common Stock | (F3) 1,052 shares will vest on December 1, 2022; 526 shares will vest on December 1, 2023; and 527 shares will vest on December 1, 2024. |
| 13 | Derivative | Non-Qualified Stock Options | 2022-05-27 | A | A | 1,892 | $0.00 | 1,892 | D | $254.00 · — to 2031-02-01 | 1,892 Common Stock | (F4) 473 shares are vested in full; the remaining 1,419 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025. |